MODIFICATION TO HYPERQ SYSTEM

Monitor, Physiological, Patient (without Arrhythmia Detection Or Alarms)

BIOLOGICAL SIGNAL PROCESSING, LTD.

The following data is part of a premarket notification filed by Biological Signal Processing, Ltd. with the FDA for Modification To Hyperq System.

Pre-market Notification Details

Device IDK072389
510k NumberK072389
Device Name:MODIFICATION TO HYPERQ SYSTEM
ClassificationMonitor, Physiological, Patient (without Arrhythmia Detection Or Alarms)
Applicant BIOLOGICAL SIGNAL PROCESSING, LTD. 291 Hillside Avenue Somerset,  MA  02726
ContactGeorge J Hattub
CorrespondentGeorge J Hattub
BIOLOGICAL SIGNAL PROCESSING, LTD. 291 Hillside Avenue Somerset,  MA  02726
Product CodeMWI  
CFR Regulation Number870.2300 [🔎]
DecisionSubstantially Equivalent (SESE)
TypeSpecial
3rd Party ReviewedNo
Combination ProductNo
Date Received2007-08-24
Decision Date2007-09-18
Summary:summary

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.